Anavex Life Sciences Corp.

Contributing Author

Recent Articles by Anavex Life Sciences Corp.

Jul-31	Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease AVXL GlobeNewswire
May-14	Anavex Life Sciences to Participate at Upcoming Healthcare Conferences AVXL GlobeNewswire
May-13	Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update AVXL GlobeNewswire
May-06	Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025 AVXL GlobeNewswire